中医临床研究
中醫臨床研究
중의림상연구
CLINICAL JOURNAL OF CHINESE MEDICINE
2014年
6期
131-132
,共2页
晚期肿瘤%益气化积方%免疫功能%凝血指标
晚期腫瘤%益氣化積方%免疫功能%凝血指標
만기종류%익기화적방%면역공능%응혈지표
Advanced cancer%Qi-tonifying and mass-eliminating prescription%Coagulation indicator
目的:研究“益气化积”方对晚期肿瘤的治疗作用。方法:采用随机、对照方法,将55例晚期肿瘤患者分为治疗组29例、对照组26例,观察2组患者治疗前后KPS评分、体重、近期客观疗效、免疫、凝血等指标。结果:治疗组KPS评分和体重均高于对照组,差异有统计学意义(P﹤0.05)。治疗组CD3、CD4、CD4/CD8升高,CD8下降,治疗前后比较有显著性差异(P﹤0.05),与对照组比较无显著性差异(P﹥0.05);治疗组Fib、PT均明显下降(P﹤0.05),与对照组比较无显著性差异(P﹥0.05);治疗组近期有效率为31.03%,高于对照组19.23%,两组比较无显著性差异(P﹥0.05)。结论:“益气化积”方能显著提高晚期肿瘤患者的KPS评分和体重,改善免疫、凝血指标,可一定程度地抑制肿瘤进展。
目的:研究“益氣化積”方對晚期腫瘤的治療作用。方法:採用隨機、對照方法,將55例晚期腫瘤患者分為治療組29例、對照組26例,觀察2組患者治療前後KPS評分、體重、近期客觀療效、免疫、凝血等指標。結果:治療組KPS評分和體重均高于對照組,差異有統計學意義(P﹤0.05)。治療組CD3、CD4、CD4/CD8升高,CD8下降,治療前後比較有顯著性差異(P﹤0.05),與對照組比較無顯著性差異(P﹥0.05);治療組Fib、PT均明顯下降(P﹤0.05),與對照組比較無顯著性差異(P﹥0.05);治療組近期有效率為31.03%,高于對照組19.23%,兩組比較無顯著性差異(P﹥0.05)。結論:“益氣化積”方能顯著提高晚期腫瘤患者的KPS評分和體重,改善免疫、凝血指標,可一定程度地抑製腫瘤進展。
목적:연구“익기화적”방대만기종류적치료작용。방법:채용수궤、대조방법,장55례만기종류환자분위치료조29례、대조조26례,관찰2조환자치료전후KPS평분、체중、근기객관료효、면역、응혈등지표。결과:치료조KPS평분화체중균고우대조조,차이유통계학의의(P﹤0.05)。치료조CD3、CD4、CD4/CD8승고,CD8하강,치료전후비교유현저성차이(P﹤0.05),여대조조비교무현저성차이(P﹥0.05);치료조Fib、PT균명현하강(P﹤0.05),여대조조비교무현저성차이(P﹥0.05);치료조근기유효솔위31.03%,고우대조조19.23%,량조비교무현저성차이(P﹥0.05)。결론:“익기화적”방능현저제고만기종류환자적KPS평분화체중,개선면역、응혈지표,가일정정도지억제종류진전。
Objective:To study therapeutic effects of qi-tonifying and mass-eliminating prescriptions to advanced cancer. Methods:55 cases of advanced cancer were randomly divided into two groups, treatment group of 29 cases and control group of 26 cases;and we observed KPS scores, weight, short-term effects, immunity and coagulation etc. indicators of the two groups. Results: KPS scores and weight of the treatment group were higher than those of the control group, the difference being statistically significant (P<0.05). CD3, CD4 and CD4/CD8 of the treatment group increased while CD8 decreased. The differences between before and after the treatment were statistically significant (P<0.05) while compared with the control group there was no significant difference (P>0.05). Both Fib and PT decreased significantly of the treatment group (P<0.05), and there was no significant difference from the control group. Short-term efficiency of the treatment group was 31.03%, which was higher than that of the control group of 19.23%, and the difference was not statistically different (P>0.05). Conclusion:Qi-tonifying and mass-eliminating prescriptions can significantly improve KPS scores, weight, immunity and coagulation indicators of advanced cancer patients, and can control cancer progression to some extent.